About CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
CSPC Pharmaceutical Group Limited is an investment holding company principally engaged in the manufacture and sales of pharmaceutical products. The Company sells its products under the brand of CSPS. The Company has four business segments: Finished Drugs, Antibiotics (intermediates and bulk drugs), Vitamin C (bulk drugs) and Caffeine and Others (bulk drugs). All these segments are engaged in the manufacture and sales of related pharmaceutical products. The finished drugs include the antibiotics, cardio-cerebrovascular drugs, diabetes drugs, neurology drugs, oncology drugs and traditional Chinese medicines. The Company is also engaged in the provision of pharmaceutical research and development services, as well as the processing of sewage and pharmaceutical by-products through its subsidiaries.
Industry, Sector and Symbol
Trailing P/E Ratio39.79
Forward P/E Ratio35.10
Sales & Book Value
Annual Sales$1.59 billion
Price / Sales7.92
Cash Flow$2.86 per share
Price / Cash35.33
Book Value$10.84 per share
Price / Book9.32
Net Income$270.58 million
Return on Equity22.35%
Return on Assets15.16%
CSPC Pharmaceutical Group (OTCMKTS:CHPTY) Frequently Asked Questions
What is CSPC Pharmaceutical Group's stock symbol?
CSPC Pharmaceutical Group trades on the OTCMKTS under the ticker symbol "CHPTY."
Who are some of CSPC Pharmaceutical Group's key competitors?
Some companies that are related to CSPC Pharmaceutical Group include Mylan (MYL), AmerisourceBergen (ABC), Lonza Group (LZAGY), Sunny Optical Tech (SNPTF), Laboratory Corp. of America (LH), Coloplast A/S (CLPBY), IDEXX Laboratories (IDXX), Eisai (ESALY), Grifols SA, Barcelona (GRFS), ResMed (RMD), Sino Biopharmaceut (SBMFF), Olympus (OCPNY), Davita (DVA), DENTSPLY SIRONA (XRAY), IPSEN (IPSEY), Perrigo (PRGO), Genmab As (GNMSF) and Straumann (SAUHF).
Who are CSPC Pharmaceutical Group's key executives?
CSPC Pharmaceutical Group's management team includes the folowing people:
- Dongchen Cai, Executive Chairman of the Board, Chief Executive Officer (Age 63)
- Weidong Pan, Executive Vice Chairman of the Board (Age 47)
- Kin Man Chak, Executive Director (Age 51)
- Hua Lu, Executive Director (Age 45)
- Jianmin Lu, Executive Director (Age 58)
- Huaiyu Wang, Executive Director (Age 53)
- Jinxu Wang, Executive Director (Age 46)
- Zhenguo Wang, Executive Director (Age 47)
- Ka Sze Lee, Company Secretary, Non-Executive Director (Age 57)
- Siu Keung Chan, Independent Non-Executive Director (Age 59)
How do I buy CSPC Pharmaceutical Group stock?
Shares of CSPC Pharmaceutical Group can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CSPC Pharmaceutical Group's stock price today?
One share of CSPC Pharmaceutical Group stock can currently be purchased for approximately $101.08.
How big of a company is CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group has a market capitalization of $12.62 billion and generates $1.59 billion in revenue each year. CSPC Pharmaceutical Group employs 10,023 workers across the globe.
How can I contact CSPC Pharmaceutical Group?
CSPC Pharmaceutical Group's mailing address is No. 226 Huanghe Avenue, SHIJIAZHUANG, HEB 050035, China. The company can be reached via phone at +86-311-87037015 or via email at [email protected]
MarketBeat Community Rating for CSPC Pharmaceutical Group (CHPTY)MarketBeat's community ratings are surveys of what our community members think about CSPC Pharmaceutical Group and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
CSPC Pharmaceutical Group (OTCMKTS:CHPTY) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
CSPC Pharmaceutical Group (OTCMKTS:CHPTY) Earnings History and Estimates Chart
CSPC Pharmaceutical Group (OTCMKTS CHPTY) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|8/22/2017||Q2 2017||$0.72||$479.02 million||View||N/A|
|5/25/2017||Q1 2017||$0.68||$447.23 million||View||N/A|
|3/20/2017||Q4 2016||$0.57||$401.99 million||View||N/A|
|11/23/2016||Q3 2016||$0.57||$400.23 million||View||N/A|
|8/23/2016||Q2 2016||$0.57||$406.17 million||View||N/A|
|5/18/2016||Q1 2016||$0.55||$385.03 million||View||N/A|
|3/21/2016||Q4 2015||$0.46||$372.97 million||View||N/A|
|11/30/2015||Q3 2015||$0.45||$357.66 million||View||N/A|
|8/25/2015||Q2 2015||$0.45||$380.32 million||View||N/A|
|5/26/2015||Q1 2015||$0.43||$358.62 million||View||N/A|
|3/24/2015||Q4 2014||$0.38||$363.04 million||View||N/A|
|11/25/2014||Q3 2014||$0.35||$360.70 million||View||N/A|
|8/26/2014||Q2 2014||$0.37||$356.03 million||View||N/A|
|5/23/2014||Q1 2014||$0.28||$332.89 million||View||N/A|
|3/24/2014||Q4 2013||$0.23||$324.60 million||View||N/A|
|5/31/2013||Q1 2013||$0.24||$328.51 million||View||N/A|
CSPC Pharmaceutical Group (OTCMKTS:CHPTY) Earnings Estimates
Current Year EPS Consensus Estimate: $2.88 EPS
Next Year EPS Consensus Estimate: $3.78 EPS
Dividend History for CSPC Pharmaceutical Group (OTCMKTS:CHPTY)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for CSPC Pharmaceutical Group (OTCMKTS CHPTY)
No insider trades for this company have been tracked by MarketBeat.com
CSPC Pharmaceutical Group (OTCMKTS CHPTY) News Headlines
CSPC Pharmaceutical Group (OTCMKTS:CHPTY) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
CSPC Pharmaceutical Group (OTCMKTS CHPTY) Stock Chart for Saturday, February, 24, 2018